Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA-DPB1*04 refers to a specific allele of the HLA-DPB1 gene, which encodes the beta chain of the HLA-DP molecule—a member of the major histocompatibility complex (MHC) class II family. The primary function of this molecule is to present peptide antigens derived from extracellular proteins to CD4+ T cells, thereby initiating and regulating immune responses. Variants like HLA-DPB1*04 play roles in susceptibility/protection for autoimmune diseases, response kinetics after vaccination/infection (e.g., hepatitis B), risk stratification for transplant outcomes due to donor-specific antibody formation, and shaping overall immunopeptidome diversity. HLA-DPB1*04-restricted presentation refers specifically to how this MHC class II variant binds select peptides for display on APC surfaces, influencing downstream adaptive immune recognition events based on its unique structural features and expression profile determined by genetic background.
Modulation of antigen presentation to CD4+ T cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA-DPB1*04.